The Effect Of Vitamin D On Measures Of Bone Health And Gene Expression
NCT ID: NCT01696409
Last Updated: 2017-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11 participants
OBSERVATIONAL
2009-07-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages
NCT02856776
Dose-dependent Effects of Vitamin D on Bone Health
NCT01900860
The Genetic Effects on Vitamin D Supplementation
NCT05802433
Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy
NCT00692120
The Effect of a Meal on Vitamin D Absorption
NCT01268176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A
400 IU vitamin D3 once a day for 2 months
400 IU vitamin D3
Take 400 IU once/day for 2 months
Arm B
2000 IU Vitamin D3 once/day for 2 months
2000 IU vitamin D3
2000 IU vitamin D3 once/day for 2 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
400 IU vitamin D3
Take 400 IU once/day for 2 months
2000 IU vitamin D3
2000 IU vitamin D3 once/day for 2 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2\. Current or recent history of hepatic or renal disease
3\. History of taking a daily supplement that contains more than 400 IU vitamin D2 or vitamin D3 within the past month or taking a pharmacologic amount of vitamin D2 or one of the active vitamin D analogs including Zemplar (Paricalcitol), Dovonex (calcipotriol), Hectorol (vitamin D pro hormone)
4\. Subjects who are taking antiseizure medications or glucocorticoids.
5\. Exposure to a tanning bed or tanning on a beach for more than eight hours within the past month.
6\. Known history of elevated calcium. (\> 10.5 mg% (mg/dl))
7\. History of intestinal malabsorption (i.e. Cystic Fibrosis, Fat Malabsorption Syndrome, Crohn's Disease)
8\. Unwilling to consent to this trial
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael F. Holick
Dr. Michael Holick
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael F Holick, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
BUMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hossein-nezhad A, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One. 2013;8(3):e58725. doi: 10.1371/journal.pone.0058725. Epub 2013 Mar 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Vitamin D and Gene Expression
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.